BioPharma, Startups An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025 By Frank Vinluan
BioPharma, Startups Seeing a Better Way for Eye Drug R&D, Character Bio Lands $93M for Two Trials in Dry AMD By Frank Vinluan
